CRDL·14161Y200·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
CRDL (CARDIOL THERAPEUTICS INC) is held by 23 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($1.1M), TWO SIGMA INVESTMENTS, LP ($721,185), GOLDMAN SACHS GROUP INC ($448,740). Net institutional sentiment: Mixed.
See how CRDL's score breaks down across 4 SEC sources
Showing 1-20 of 29
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer